(Please note: Due to security concerns, names have been kept confidential. To request an unedited version, please contact Business Development at 510.964.9000.)
Hercules, CA – Pacific BioLabs (PBL), The Service Leader in Bioscience Testing, is pleased to announce the addition of a new Vice President of Toxicology. Dennis _____, Ph.D. will direct all aspects of Toxicology and In Vivo services and will assist PBL clients with designing and managing their preclinical drug development and safety programs.
Dr. _____ relocated from San Diego to the Bay Area to take advantage of the opportunity to work with PBL’s clients and staff. “Working as I have in the biotech industry, I am intimately aware of how important it is to have a resource like PBL, where top-notch study directors provide a quality product in a timely fashion,” he commented. “And from a professional point of view, where else do you have the opportunity to significantly contribute to so many different projects in so many different areas of toxicology and drug development?”
Before joining PBL, Dr. _____ was Senior Director of Preclinical Development for Avera Pharmaceuticals in San Diego, where he had overall responsibility for Safety Pharmacology, Toxicology and ADME studies supporting clinical development of CNS active drugs. Prior to Avera, he was Senior Director of Drug Metabolism and Pharmacokinetics at Arena Pharmaceuticals. There, he was responsible for DMPK support of small molecule drug discovery and development efforts in multiple therapeutic areas. His 30 years of experience include preclinical development positions with both San Diego biotech and East Coast pharmaceutical companies. He was active in the San Diego drug metabolism community and a founding member of the Southern California Drug Metabolism Discussion Group.
According to the President of PBL, “Dennis’s broad background in PK/ADME, drug metabolism, and pharmaceutical toxicology will help our clients design safer drugs and get faster regulatory approvals. He has experience with Big Pharma, small biotechs, and ‘virtual’ drug development companies, so he’s familiar with the challenges at all levels of the pharmaceutical industry. I’m confident he will make major contributions to the success of our clients.”
About Pacific BioLabs – Since 1982, Pacific BioLabs has delivered GMP/GLP testing services to the pharmaceutical, biotech, medical device, and specialty chemical industries. PBL specializes in toxicology for FDA, EPA and international regulatory submissions, as well as drug development support projects such as disease model development, drug delivery studies, and PK/ADME. PBL is located in the San Francisco Bay Area. The company is ISO 9001:2000 certified and AAALAC accredited.
For additional information please contact: